NASDAQConsumer DiscretionaryApparel - Footwear & AccessoriesSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Manage capital allocation through equity sales and debt | American Rebel Holdings is actively managing capital by issuing equity and raising loans totaling over $570,000. | Under Pressure | capital raised falls below $500,000 in next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 recent quarters with multiple unregistered equity sales and issuance of restricted shares as commitment shares. The company raised capital through equity sales valued in tens of thousands of dollars per transaction, including $51,250 and $71,788 in recent months. This shows ongoing capital allocation activity consistent with management's stated priority. Delivery assessment Oct 24, 2026 |
Engage in M&A activities for strategic growth | A primary condition in AMERICAN REBEL HOLDINGS INC's published investment case. The stated target is Complete at least two material M&A deals worth $300,000+ in next 12 months. | Under Pressure | fewer than two deals or deals under $300,000 in next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 recent quarters via material definitive agreements and capital raises. The company issued convertible promissory notes totaling $137,500 in September 2026 and $135,000 in July 2026 to support strategic growth. These capital raises demonstrate ongoing M&A and financing activity consistent with management's stated priority. Delivery assessment Oct 24, 2026 |
Address regulatory compliance issues | A supporting condition in AMERICAN REBEL HOLDINGS INC's published investment case. The stated target is Resolve all regulatory compliance issues within next 12 months. | Intact | regulatory issues remain unresolved or worsen beyond current status | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making business with volatile management and weak recent performance, rather than an established compounder. Its multi-year view is in a watch state, and the latest signal has become more restrictive.
The valuation evidence describes AREB as cheap versus peers, but confidence in that comparison is low. The expectations gap is negative, while the priced-in assessment is tagged justified and shows low fragility, so the evidence does not point to a clear mismatch between expectations and the business outlook.
Near term, revenue has stayed near $1.99 million in both 2026-Q1 and 2026-Q2, despite management's focus on turning a $3.9 million Champion Safe backlog into shipments. Financing and equity issuance continue alongside M&A activity, but a recent acquisition announcement and termination of a material agreement show mixed execution. The next results carry elevated risk because the company is small and has a history of a deep miss.
The multi-year thesis depends on whether manufacturing and fulfillment improvements convert backlog into sustained revenue growth. M&A progress and the terms of ongoing financing also matter, especially given the recent agreement termination and equity sales. Near term, sector bellwether results could support or weaken the sector backdrop, while GDP growth below 2% would be a specific risk to this growth-sensitive business.
Over the next 1 to 3 years, the central question is whether AREB can turn operational priorities and financing activity into stronger business results. Current evidence shows limited revenue progress and high execution risk, so the long-term thesis remains under watch. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.